The article reports that high-dose flu vaccines, typically administered to those aged 65 and older, may also be more effective for adults aged 50 to 64, as observational data from over 1.6 million people suggests a 15 percent reduction in flu cases with a recombinant va...
High-Dose Flu Vaccine Leads to Less Cardio-Respiratory Events in StudyDa Hee HanPharmD
A recent study reveals the QIV-HD vaccine significantly lowers hospitalization rates compared to the standard-dose vaccine (QIV-SD). A randomized DANFLU-1 clinical vaccine trial, as documented in Clinical Microbiology and Infection compared the QIV-HD with the QIV-SD. The vaccine...
“This long-term analysis across five flu seasons — 2010-2011 through 2014-2015 — provides a succinct appraisal of the high-dose vaccine’s effectiveness over the standard-dose vaccine,”YinongYoung-Xu,ScD, director of the clinical epide...
(HealthDay)—HIV-infected adults achieve higher rates of seroprotection when immunized with a high-dose of the influenza trivalent vaccine compared to the standard dose, according to a study published in the Jan. 1 issue of the Annals of Internal Medicin
Fluzone High-Dose (InfluenzaVaccine) forintramuscularinjection is an inactivated influenza vaccine, prepared from influenzavirusespropagated in embryonated chicken eggs. The virus-containing allantoic fluid is harvested and inactivated with formaldehyde. Influenza virus is concentrated and purified in a linea...
Fluzone High-Dose is a flu vaccine for people age 65 and older that's given by injection. Like other flu vaccines, Fluzone High-Dose is made up of the three flu strains most likely to cause the flu during the upcoming flu season. A new vaccine called Flu
High-dose flu vaccine for 2010-2011.(CLINICAL ROUNDS)Schneider, Mary Ellen
Fluzone High-Dose Quadrivalent is a vaccine that helps protect people 65 years of age and older against influenza illness (flu). Vaccination with Fluzone High-Dose Quadrivalent vaccine may not protect all people who receive the vaccine.
“To our knowledge, however, no studies have compared these formulations to a standard-dose vaccine in people living with chronic rheumatic diseases,” they added. “Because of the disproportionally high burden of influenza in patients ...